“In Phase 3 clinical trials, across a broad range of genotypes, once-daily ALYFTREK demonstrated non-inferiority to TRIKAFTA in ppFEV 1 response and statistically significant improvement in ...

You may only get a mild skin rash or an ear or eye infection. Or you may have already had a pseudomonas infection and didn't realize it. For instance, Pseudomonas aeruginosa can cause swimmer's ...

Participants were randomly assigned to receive Trikafta or placebo based on age and weight: Aged 6 to < 12 years and less than 30 kg: morning dose of elexacaftor 100 mg/tezacaftor 50 mg/ivacaftor ...

Sales are expected to surpass that total in 2024. Like Vertex’s top-selling drug Trikafta, Alyftrek is a three-drug combination that uses a compound called tezacaftor as its chemical backbone. The two ...

SEOUL – Female K-pop idols have opened up about the severe pressure of extreme dieting and societal beauty standards in the SBS documentary “Bodymentary”, which aired on Dec 31. From ...

Jinhsi's alternate outfit "Peach Blossom" will be available for 2680 Lunites in Version 2.0. The outfit includes a new weapon projection, Sigil, avatar, and animations. Kuro Games may release ...

When a tick embeds in your skin, the site may appear red or purple. After the bite, a skin rash is common, especially in the case of a tick-borne illness. The rash can look like a bullseye and is ...

Courtesy of Gunnar Esiason After a few particularly nasty years battling CF, Gunnar entered into a clinical trial in 2018 for a drug called Trikafta, which had received funding from the Boomer ...

Gunnar even proposed to Darcy while ice skating. Courtesy of Gunnar Esiason After a few particularly nasty years battling CF, Gunnar entered into a clinical trial in 2018 for a drug called Trikafta, ...

It causes relatively large, tough, flesh-colored bumps. Heat rashes are not often dangerous, but if symptoms last longer than a few days or signs of an infection appear, see a healthcare provider.

It will be marketed as Alyftrek. Vertex also won expanded approval for Trikafta, which was first approved in 2019. Trikafta has become Vertex’s (Nasdaq: VRTX) blockbuster CF drug, helping drive ...